Pharmacotherapy to Improve Cognitive Functioning After Acquired Brain Injury: A Meta‐Analysis and Meta‐Regression
Clinical Pharmacology & Therapeutics · 2024-05 · 115 (5) · 971-987
DOI: 10.1002/cpt.3186 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 31.01.2024. Verfasst von Ruud van der Veen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Follow Me Program & Emma Neuroscience Group, Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amst…. Hauptthemen laut MEDLINE: Methylphenidate, Cognition, Cognitive Dysfunction. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Cognitive impairments, common sequelae of acquired brain injury (ABI), significantly affect rehabilitation and quality of life. Currently, there is no solid evidence‐base for pharmacotherapy to improve cognitive functioning after ABI, nevertheless off‐label use is widely applied in clinical practice. This meta‐analysis and meta‐regression aims to quantitatively aggregate the available evidence for the effects of pharmacological agents used in the treatment of cognitive impairments following ABI. We conducted a comprehensive search of Embase, Medline Ovid, and Cochrane Controlled Trials Register databases for randomized controlled and crossover trials. Meta‐analytic effects were calculated for each pharmaceutical agent and targeted neuromodulator system. Cognitive outcome measures were aggregated across cognitive domains. Of 8,216 articles, 41 studies (4,434 patients) were included. The noradrenergic agent methylphenidate showed a small, significant positive effect on cognitive functioning in patients with traumatic brain injury (TBI; k = 14, d = 0.34, 95% confidence interval: 0.12–0.56, P = 0.003). Specifically, methylphenidate was found to improve cognitive functions related to executive memory, baseline speed, inhibitory control, and variability in responding. The cholinergic drug donepezil demonstrated a large effect size, albeit based on a limited number of studies ( k = 3, d = 1.68, P = 0.03). No significant effects were observed for other agents. Additionally, meta‐regression analysis did not identify significant sources of heterogeneity in treatment response. Our meta‐analysis supports the use of methylphenidate for enhancing cognitive functioning in patients with TBI. Although donepezil shows potential, it warrants further research. These results could guide clinical decision making, inform practice guidelines, and direct future pharmacotherapeutic research in ABI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Follow Me Program & Emma Neuroscience Group, Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam Reproduction and Development Research Institute, Amsterdam, The…
- Daan Theeuwes Center for Intensive Neurorehabilitation, Woerden, The Netherlands.
- Reade, Amsterdam Rehabilitation Research Centre, Amsterdam, The Netherlands.
- Department of Neurosurgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
ORCID-Profile: Ruud van der Veen, Marsh Königs, Saskia Peerdeman, Pierre M Bet, Jaap Oosterlaan
Zitieren
APA
van der Veen, R., Königs, M., Bakker, S., van Iperen, A., Peerdeman, S., Bet, P. M., & Oosterlaan, J. (2024). Pharmacotherapy to Improve Cognitive Functioning After Acquired Brain Injury: A Meta‐Analysis and Meta‐Regression. Clinical Pharmacology & Therapeutics, 115(5), 971-987. https://doi.org/10.1002/cpt.3186
Vancouver
van der Veen R, Königs M, Bakker S, van Iperen A, Peerdeman S, Bet PM, et al. Pharmacotherapy to Improve Cognitive Functioning After Acquired Brain Injury: A Meta‐Analysis and Meta‐Regression. Clinical Pharmacology & Therapeutics. 2024;115(5):971-987. doi:10.1002/cpt.3186
BibTeX
@article{vanderVeen2024,
author = {van der Veen, Ruud and Königs, Marsh and Bakker, Simon and van Iperen, Andries and Peerdeman, Saskia and Bet, Pierre M and Oosterlaan, Jaap},
title = {Pharmacotherapy to Improve Cognitive Functioning After Acquired Brain Injury: A Meta‐Analysis and Meta‐Regression},
journal = {Clinical Pharmacology & Therapeutics},
year = {2024},
volume = {115},
number = {5},
pages = {971--987},
doi = {10.1002/cpt.3186}
}
EUVIMED